20 Oct 2020 Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study Member news
19 Oct 2020 CANNOVEX receives EUR 0.5 million grant for development of nanofibrous films for transmucosal uptake of cannabinoids Member news
16 Oct 2020 Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients Member news
15 Oct 2020 Sequana Medical appoints two additional experts as Heart Failure Scientific Advisors Member news
14 Oct 2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
